Eleonora Pagnotta

Dr. Eleonora Pagnotta

CREA-Council for Agricultural Research and Economics, Research Centre for Cereal and Industrial Crops, Bologna, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2003 in Gastroenterology
Verified
Journal Article
Closed access
Roberto De GiorgioRoberto De Giorgio
Roberto De Giorgio
MBMonica Bovara
Monica Bovara
GBGiovanni Barbara
Giovanni Barbara
Marco CanossaMarco Canossa
Marco Canossa
GSGiovanni Sarnelli
Giovanni Sarnelli
RCRoberto Corinaldesi
Roberto Corinaldesi

1 May 2017 in International Journal of Food Microbiology
Verified
Journal Article
Closed access
AFAlessandra Di Francesco
Alessandra Di Francesco
LULuisa Ugolini
Luisa Ugolini
SDSalvatore D'Aquino
Salvatore D'Aquino
Eleonora PagnottaEleonora Pagnotta
Eleonora Pagnotta
MMMarta Mari
Marta Mari

1 July 2007 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
Alessandra BaraccaAlessandra Baracca
Alessandra Baracca
GSGianluca Sgarbi
Gianluca Sgarbi
MMMarina Mattiazzi
Marina Mattiazzi
GCGabriella Casalena
Gabriella Casalena
Eleonora PagnottaEleonora Pagnotta
Eleonora Pagnotta
Giancarlo SolainiGiancarlo Solaini
Giancarlo Solaini

10 January 2019 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
VCValentina Citi
Valentina Citi
EPEugenia Piragine
Eugenia Piragine
Eleonora PagnottaEleonora Pagnotta
Eleonora Pagnotta
LULuisa Ugolini
Luisa Ugolini
Lorenzo Di Cesare MannelliLorenzo Di Cesare Mannelli
Lorenzo Di Cesare Mannelli
Alma MartelliAlma Martelli
Alma Martelli

1 November 2013 in Food Chemistry
Verified
Journal Article
Closed access
GNGina Rosalinda De Nicola
Gina Rosalinda De Nicola
MBManuela Bagatta
Manuela Bagatta
Eleonora PagnottaEleonora Pagnotta
Eleonora Pagnotta
Donato AngelinoDonato Angelino
Donato Angelino
LGLorenzo Gennari
Lorenzo Gennari
RIRenato Iori
Renato Iori

2 March 2019 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
Alma MartelliAlma Martelli
Alma Martelli
EPEugenia Piragine
Eugenia Piragine
VCValentina Citi
Valentina Citi
Lara TestaiLara Testai
Lara Testai
Eleonora PagnottaEleonora Pagnotta
Eleonora Pagnotta
VCVincenzo Calderone
Vincenzo Calderone
Background and Purpose: Hydrogen sulfide (H2S)‐releasing agents are viewed as potential antihypertensive drugs. Recently, natural isothiocyanates emerged as original H2S‐donor agents. Among them, erucin, present in some edible cruciferous plants, shows suitable H2S‐releasing properties and features of “druggability.” The aim of this work was to investigate the erucin‐mediated release of H2S inside vascular cells, its vasorelaxing effects, and activity on BP of normo and hypertensive animals.Experimental Approach: Intracellular H2S‐release and the hyperpolarizing effect of erucin were tested using fluorescent dye, in human aortic smooth muscle cells (HASMCs). Its direct vasorelaxing effect and ability to inhibit noradrenaline‐induced vasoconstriction were evaluated on endothelium‐intact or ‐denuded rat aortic rings. Its vasodilator properties were tested in coronary arteries using Langendorff‐perfused rat hearts. Finally, erucin's antihypertensive activity was evaluated in vivo in normotensive and spontaneously hypertensive rats (SHRs) by recording systolic BP using the tail‐cuff method.Key Results: Erucin induced the release of H2S inside HASMCs. Moreover, erucin hyperpolarized the membrane of HASMCs membrane in a concentration‐dependent manner. It induced vasodilatation of rat aortic rings, in endothelium‐denuded vessels. This effect was further improved by the presence of endothelial NO. When pre‐incubated with rat aortic rings, erucin induced concentration‐dependent inhibition of noradrenaline‐induced vasoconstriction. Erucin did not affect basal coronary flow but restored the flow to normal in pre‐contracted coronary vessels. Finally, in vivo, erucin decreased systolic BP in SHRs by about 25%, and restored the BP to values observed in normotensive rats.Conclusions and Implications: Erucin is an H2S donor endowed with vasorelaxing and antihypertensive effects.Linked Articles: This article is part of a themed section on Hydrogen Sulfide in Biology & Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.4/issuetoc